ArticleVaccines2023

A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers.

Urska Janzic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.